[{"Assets_0_Q2_USD":420772000.0,"CommonStockSharesOutstanding_0_Q2_shares":29424013.0,"NetIncomeLoss_1_Q2_USD":-11610000.0,"NetIncomeLoss_2_Q2_USD":-26117000.0,"StockholdersEquity_0_Q2_USD":240790000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":29351537.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":29256602.0,"Ticker":"NVRO","CIK":"1444380","name":"NEVRO CORP","OfficialName":"Nevro Corp. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2648227724.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20170807"}]